TWD 572.0
(-1.38%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 3.32 Billion TWD | 4.07% |
2022 | 3.19 Billion TWD | 63.85% |
2021 | 1.94 Billion TWD | 20.87% |
2020 | 1.61 Billion TWD | 128.79% |
2019 | 704.33 Million TWD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 2.82 Billion TWD | -15.05% |
2024 Q2 | 2.87 Billion TWD | 1.95% |
2023 Q3 | 3.03 Billion TWD | 27.8% |
2023 FY | 3.32 Billion TWD | 4.07% |
2023 Q1 | 4.42 Billion TWD | 38.58% |
2023 Q2 | 2.37 Billion TWD | -46.35% |
2023 Q4 | 3.32 Billion TWD | 9.53% |
2022 Q3 | 2.01 Billion TWD | 0.0% |
2022 Q4 | 3.19 Billion TWD | 58.38% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Grape King Bio Ltd | 3.88 Billion TWD | 14.445% |
Standard Chem & Pharm CO., LTD. | 3.05 Billion TWD | -8.841% |
Maywufa Company Ltd. | 794.91 Million TWD | -317.802% |
ScinoPharm Taiwan, Ltd. | 1.35 Billion TWD | -144.715% |
Lotus Pharmaceutical Co., Ltd. | 15.65 Billion TWD | 78.789% |
LIWANLI Innovation Co., Ltd. | 50.66 Million TWD | -6455.797% |
YungShin Global Holding Corporation | 3.59 Billion TWD | 7.681% |
PhytoHealth Corporation | 79.84 Million TWD | -4059.309% |
SCI Pharmtech, Inc. | 1.59 Billion TWD | -108.775% |
Formosa Laboratories, Inc. | 5.42 Billion TWD | 38.792% |
Bora Pharmaceuticals Co., LTD. | 13.28 Billion TWD | 75.003% |